30 PENHALLOW STREET, SUITE 400,
PORTSMOUTH , NH, 03801
PORTSMOUTH , NH, 03801
Summary
The fund seeks to provide total return that replicate the price and yield performance of the benchmark index before fees and expenses by investing in mid-and large-size companies outside the United States.
The investment process starts with a list of companies in the benchmark index and the research team utilizes quantitative techniques and fundamental analysis to identify investment opportunities.
The fund employs a passiv More
Link
Directors
Mar 11, 2024- John L. Liechty
- D'Anne Hurd
- Gregory D. Sheehan
- Lindsey Brace Martinez
- Nancy S. Taylor
- Adrian P. Anderson
- Anne M. Goggin
- Joseph Keefe
Chief Compliance Officer
- JOHN BOESE
Fund Manager(s)
- Scott LaBreche
- Christine Cappabianca
Price
- 52-Week High/Low
- $11.86 - $10.11
- Turnover
- 51%
- Expense Ratio
- 0.72%
Company Name |
Holding |
| Novo Nordisk A/S | 3.4 % |
| ASML Holding NV | 2.98 % |
| AstraZeneca plc | 2.69 % |
| Novartis AG | 2.65 % |
| HSBC Holdings plc | 2.36 % |
| Schneider Electric SE | 2.25 % |
| CSL Ltd. | 2.03 % |
| BNP Paribas SA | 1.91 % |
| RELX plc | 1.9 % |
| Tokyo Electron Ltd. | 1.87 % |
| More | 1.87 % |
Performance
YTD
-
3 Year
32.16%
5 Year
48.53%
Best
39.1%
2009
Worst
-19.93%
2022
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Q1 | - | - | 5% | 8.8% | -8.1% | -0.5% | -21.3% | 9.1% | -1.1% | 7.7% |
| Q2 | - | - | -3.8% | 1.8% | -15.7% | 7.2% | 15.5% | 1.5% | -0.5% | 5.8% |
| Q3 | - | - | - | -5.4% | -11.6% | -4% | 2.6% | -0.7% | 2.9% | 4.8% |
| Q4 | - | - | - | 12.8% | 17% | 3.5% | 14.8% | 7.7% | -12.1% | 3.1% |
| J | F | M | A | M | J | J | A | S | O | N | D | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2025 | - | - | - | - | - | - | - | - | - | - | - | - |
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| 0% | 0% | -1% | 16% | -20% | 6% | 9% | 20% | -13% | 23% |
Alpha
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PXINX | - | - | -1% | 16% | -20% | 6% | 9% | 20% | -13% | 23% |
| S&P 500 | - | - | - | - | -21% | 27% | 16% | 29% | -6% | 19% |
| Alpha | - | - | -1% | 16% | 1% | -21% | -8% | -9% | -7% | 4% |